Variability in HbA1c and the risk of major clinical outcomes in type 2 diabetes with chronic kidney disease: Post hoc analysis from the CREDENCE trial

被引：0
作者：
Zhu, Ying [1 ,2 ]
Jun, Min [1 ]
Fletcher, Robert A. [1 ]
Arnott, Clare [1 ,3 ]
Neuen, Brendon L. [1 ,4 ]
Kotwal, Sradha S. [1 ,5 ]
机构：
[1] Univ New South Wales, George Inst Global Hlth, Sydney, Australia
[2] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Sch Med, Dept Endocrinol, Chengdu, Peoples R China
[3] Univ Sydney, Royal Prince Alfred Hosp, Camperdown, Australia
[4] Univ Sydney, Royal North Shore Hosp, St Leonards, Australia
[5] Univ New South UK, Prince Wales Hosp, Randwick, Australia
来源：
DIABETES OBESITY & METABOLISM | 2025年 / 27卷 / 06期
关键词：
chronic kidney disease; clinical outcomes; HbA1c variability; type; 2; diabetes;
D O I：
10.1111/dom.16363
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3531 / 3535
页数：5
相关论文
共 14 条
  • [1] Machine learning based study of longitudinal HbA1c trends and their association with all-cause mortality: Analyses from a National Diabetes Registry
    Cahn, Avivit
    Zuker, Inbar
    Eilenberg, Roni
    Uziel, Moshe
    Tsadok, Meytal Avgil
    Raz, Itamar
    Lutski, Miri
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2022, 38 (01)
  • [2] Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study
    Cardoso, C. R. L.
    Leite, N. C.
    Moram, C. B. M.
    Salles, G. F.
    [J]. CARDIOVASCULAR DIABETOLOGY, 2018, 17
  • [3] HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target
    Ceriello, Antonio
    Lucisano, Giuseppe
    Prattichizzo, Francesco
    La Grotta, Rosalba
    Franzen, Stefan
    Svensson, Ann-Marie
    Eliasson, Bjorn
    Nicolucci, Antonio
    [J]. CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [4] KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE
    de Boer, Ian H.
    Rossing, Peter
    Caramori, M. Luiza
    Chan, Juliana C. N.
    Heerspink, Hiddo J. L.
    Hurst, Clint
    Khunti, Kamlesh
    Liew, Adrian
    Michos, Erin D.
    Navaneethan, Sankar D.
    Olowu, Wasiu A.
    Sadusky, Tami
    Tandon, Nikhil
    Tuttle, Katherine R.
    Wanner, Christoph
    Wilkens, Katy G.
    Zoungas, Sophia
    Jadoul, Michel
    Winkelmayer, Wolfgang C.
    Tonelli, Marcello A.
    Craig, Jonathan C.
    Strippoli, Giovanni F. M.
    Tunnicliffe, David J.
    Higgins, Gail Y.
    Natale, Patrizia
    Cooper, Tess E.
    Willis, Narelle S.
    [J]. KIDNEY INTERNATIONAL, 2022, 102 (05) : S1 - S127
  • [5] Glycemic Targets: Standards of Care in Diabetes-2023
    ElSayed, Nuha A.
    Aleppo, Grazia
    Aroda, Vanita R.
    Bannuru, Raveendhara R.
    Brown, Florence M.
    Bruemmer, Dennis
    Collins, Billy S.
    Hilliard, Marisa E.
    Isaacs, Diana
    Johnson, Eric L.
    Kahan, Scott
    Khunti, Kamlesh
    Leon, Jose
    Lyons, Sarah K.
    Perry, Mary Lou
    Prahalad, Priya
    Pratley, Richard E.
    Seley, Jane Jeffrie
    Stanton, Robert C.
    Gabbay, Robert A.
    [J]. DIABETES CARE, 2023, 46 : S97 - S110
  • [6] Mean HbA1c, HbA1c variability, and mortality in people with diabetes aged 70 years and older: a retrospective cohort study
    Forbes, Angus
    Murrells, Trevor
    Mulnier, Henrietta
    Sinclair, Alan J.
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (06) : 476 - 486
  • [7] Haploinsufficiency of Cyfip2 Causes Lithium-Responsive Prefrontal Dysfunction
    Lee, Seung-Hyun
    Zhang, Yinhua
    Park, Jina
    Kim, Bowon
    Kim, Yangsik
    Lee, Sang Hoon
    Kim, Gyu Hyun
    Huh, Yang Hoon
    Lee, Bokyoung
    Kim, Yoonhee
    Lee, Yeunkum
    Kim, Jin Yong
    Kang, Hyojin
    Choi, Su-Yeon
    Jang, Seil
    Li, Yan
    Kim, Shinhyun
    Jin, Chunmei
    Pang, Kaifang
    Kim, Eunjeong
    Lee, Yoontae
    Kim, Hyun
    Kim, Eunjoon
    Choi, Jee Hyun
    Kim, Jeongjin
    Lee, Kea Joo
    Choi, Se-Young
    Han, Kihoon
    [J]. ANNALS OF NEUROLOGY, 2020, 88 (03) : 526 - 543
  • [8] Mao Yuanjie, 2024, J Diabetes Sci Technol, V18, P380, DOI 10.1177/19322968221100833
  • [9] Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
    Perkovic, V.
    Jardine, M. J.
    Neal, B.
    Bompoint, S.
    Heerspink, H. J. L.
    Charytan, D. M.
    Edwards, R.
    Agarwal, R.
    Bakris, G.
    Bull, S.
    Cannon, C. P.
    Capuano, G.
    Chu, P. -L.
    De Zeeuw, D.
    Greene, T.
    Levin, A.
    Pollock, C.
    Wheeler, D. C.
    Yavin, Y.
    Zhang, H.
    Zinman, B.
    Meininger, G.
    Brenner, B. M.
    Mahaffey, K. W.
    McGuire, Darren K.
    Holman, Rury
    Home, Philip
    Scharfstein, Dan
    Parfrey, Patrick
    Shahinfar, Shahnaz
    August, Phyllis
    Chang, Tara
    Sinha, Arjun D.
    Januzzi, James
    Kolansky, Daniel
    Amerena, John
    Hillis, Graham
    Gorelick, Philip
    Kissela, Brett
    Kasner, Scott
    Lindley, Richard
    Fulcher, Greg
    Ounadjela, Souhila
    Hufert, Karina
    von Ingersleben, Gabriele
    Gaglia, Jason
    Harris, Ronald
    Hudson, Margo
    Turchin, Alexander
    Cheifetz, Adam
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (24) : 2295 - 2306
  • [10] Association between visit-to-visit HbA1c variability and the risk of cardiovascular disease in patients withtype 2diabetes
    Shen, Yun
    Zhou, Jian
    Shi, Lizheng
    Nauman, Elizabeth
    Katzmarzyk, Peter T.
    Price-Haywood, Eboni G.
    Horswell, Ronald
    Bazzano, Alessandra N.
    Nigam, Somesh
    Hu, Gang
    [J]. DIABETES OBESITY & METABOLISM, 2021, 23 (01) : 125 - 135
12